188 related articles for article (PubMed ID: 30267591)
1. The impact of positive antinuclear antibody on narrowband ultraviolet B phototherapy in patients with vitiligo: A retrospective chart review.
Nahhas AF; Nartker NT; Braunberger TL; Jacobsen G; Hamzavi IH
Photodermatol Photoimmunol Photomed; 2019 Mar; 35(2):106-109. PubMed ID: 30267591
[TBL] [Abstract][Full Text] [Related]
2. The necessity of antinuclear antibody investigation in pre-phototherapy vitiligo patients: A retrospective study.
Chaiyabutr C; Wongpraparut C; Charoenpipatsin N; Pruksaeakanan C; Silpa-Archa N
Photodermatol Photoimmunol Photomed; 2020 Sep; 36(5):373-377. PubMed ID: 32274836
[TBL] [Abstract][Full Text] [Related]
3. Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy.
Bae JM; Ju HJ; Lee RW; Oh SH; Shin JH; Kang HY; Park JH; Kim HJ; Jeong KH; Lee HJ; Lee S; Kim DH; Lee DY; Kim YC; Choi GS; Kim KH; Park CJ; Choi CW;
JAMA Dermatol; 2020 May; 156(5):529-537. PubMed ID: 32159729
[TBL] [Abstract][Full Text] [Related]
4. The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo.
Mohammad TF; Al-Jamal M; Hamzavi IH; Harris JE; Leone G; Cabrera R; Lim HW; Pandya AG; Esmat SM
J Am Acad Dermatol; 2017 May; 76(5):879-888. PubMed ID: 28216034
[TBL] [Abstract][Full Text] [Related]
5. Psoralen and narrowband UVB combination provides higher efficacy in treating vitiligo compared with narrowband UVB alone: A randomised clinical trial.
Zabolinejad N; Maleki M; Salehi M; Ashrafi Z; Molkara S; Layegh P
Australas J Dermatol; 2020 Feb; 61(1):e65-e69. PubMed ID: 31651037
[TBL] [Abstract][Full Text] [Related]
6. The effect of narrowband ultraviolet B phototherapy on antinuclear antibody status: A case-control study.
Kutlu O; Ozdemir Cetinkaya P; Karaosmanoglu N; Karaaslan E; Kiratli Nalbant E; Eksioglu M
Photodermatol Photoimmunol Photomed; 2020 Nov; 36(6):470-475. PubMed ID: 32810337
[TBL] [Abstract][Full Text] [Related]
7. Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians.
Natta R; Somsak T; Wisuttida T; Laor L
J Am Acad Dermatol; 2003 Sep; 49(3):473-6. PubMed ID: 12963911
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of combined oral minocycline and narrowband UVB phototherapy in vitiligo: A randomized, double-blind, placebo-controlled trial.
Charoenpongpun N; Kamanamool N; Udompataikul M; Khunkhet S; Kanokrungsee S
Dermatol Ther; 2022 Aug; 35(8):e15596. PubMed ID: 35608017
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of homocysteine, folate and vitamin B12 in patients with vitiligo before and after treatment with narrow band ultraviolet B phototherapy and in a group of controls.
Ataş H; Cemil BÇ; Gönül M; Baştürk E; Çiçek E
J Photochem Photobiol B; 2015 Jul; 148():174-180. PubMed ID: 25941975
[TBL] [Abstract][Full Text] [Related]
10. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone.
Bansal S; Sahoo B; Garg V
Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):311-7. PubMed ID: 24118425
[TBL] [Abstract][Full Text] [Related]
11. Effect of combination NSAID and NBUVB treatment in non-photoadapters-A pilot study.
Mehta C; Mohammad T; Mehta D; Griffith J; Nicholson C; Hamzavi I
Photodermatol Photoimmunol Photomed; 2019 Sep; 35(5):318-321. PubMed ID: 31004553
[TBL] [Abstract][Full Text] [Related]
12. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
13. Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients.
Chia BKY; Yew YW; Zhao X; Chong WS; Thng TGS
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):343-350. PubMed ID: 36345565
[TBL] [Abstract][Full Text] [Related]
14. Impact on Quality of Life in Vitiligo Patients Treated with Narrowband Ultraviolet B Phototherapy.
Chahar YS; Singh PK; Sonkar VK; Rajani I; Adil M
Indian J Dermatol; 2018; 63(5):399-402. PubMed ID: 30210161
[TBL] [Abstract][Full Text] [Related]
15. Surrounding Needling and Narrowband Ultraviolet B Phototherapy Treatment: Synergistic Effects for Repigmentation in Chronic, Stable Nonsegmental Vitiligo.
Chu GY; Weng SM; Huang CC; Liang WC; Hsu CH
Altern Ther Health Med; 2023 Jan; 29(1):96-103. PubMed ID: 35212646
[TBL] [Abstract][Full Text] [Related]
16. Phototherapy for Vitiligo: A Systematic Review and Meta-analysis.
Bae JM; Jung HM; Hong BY; Lee JH; Choi WJ; Lee JH; Kim GM
JAMA Dermatol; 2017 Jul; 153(7):666-674. PubMed ID: 28355423
[TBL] [Abstract][Full Text] [Related]
17. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
[TBL] [Abstract][Full Text] [Related]
18. Tacalcitol: a useful adjunct to narrow-band ultraviolet-B phototherapy in vitiligo.
Sahu P; Jain VK; Aggarwal K; Kaur S; Dayal S
Photodermatol Photoimmunol Photomed; 2016 Sep; 32(5-6):262-268. PubMed ID: 27552149
[TBL] [Abstract][Full Text] [Related]
19. Acceleration of melanocyte senescence by the proinflammatory cytokines IFNγ and TNFα impairs the repigmentation response of vitiligo patients to narrowband ultraviolet B (NBUVB) phototherapy.
Dong BQ; Liao ZK; Le Y; Jiang S; Luo LF; Miao F; Le Poole IC; Lei TC
Mech Ageing Dev; 2023 Apr; 211():111779. PubMed ID: 36731753
[TBL] [Abstract][Full Text] [Related]
20. Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study.
Hong SB; Park HH; Lee MH
J Korean Med Sci; 2005 Apr; 20(2):273-8. PubMed ID: 15832000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
